Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ethinylestradiol/norethisterone oral - Allergan

Drug Profile

Ethinylestradiol/norethisterone oral - Allergan

Alternative Names: Estrophasic Estrostep; Estrostep; Ethinylestradiol/norethisterone; Ethinylestradiol/norethisterone acetate; Lo Loestrin; Lo Minastrin Fe; Loestrin 24; Loestrin 24 Fe; Lomedia® 24 Fe; Minastrin 24 Fe; Norethisterone acetate/ethinylestradiol; Norethisterone/ethinylestradiol; WC3040

Latest Information Update: 09 Mar 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Parke-Davis Pharmaceutical Division; Warner Chilcott
  • Developer Warner Chilcott
  • Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes; Norpregnenes; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne vulgaris; Pregnancy

Most Recent Events

  • 07 Nov 2013 Loestrin® 24 Fe withdrawn from the market for oral Pregnancy (Prevention) in USA
  • 01 Oct 2013 Warner Chilcott has been acquired and merged into Actavis Inc
  • 08 Aug 2013 Ethinylestradiol/norethisterone 0.02mg/1mg chewable tablets (Minastrin™ 24 Fe) chewable tablets launched for Pregnancy (Prevention) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top